Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers

Journal of Nuclear Medicine - Tập 58 Số 7 - Trang 1037-1042 - 2017
Gary A. Ulaner1,2, Debra A. Goldman3, Adriana Corben4, Serge K. Lyashchenko1,5, Mithat Gönen3, Jason S. Lewis1,2,6,5, Maura N. Dickler7
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
4Department of Pathology, Weill Cornell Medical College, New York, New York
5Radiochemistry and Molecular Imaging Probes Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York
6Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York
7Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.2967/jnumed.112.113100

Shoup, 1999, Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors, J Nucl Med., 40, 331

10.1007/s11307-012-0606-7

10.1016/j.juro.2013.10.065

10.2967/jnumed.114.143628

10.1148/radiol.13130240

10.2967/jnumed.115.170456

10.2967/jnumed.115.171389

Kondo, 2016, Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors, Ann Nucl Med., 30, 608, 10.1007/s12149-016-1102-y

10.1007/s00259-016-3329-1

10.1007/s00259-016-3383-8

10.1177/0284185115581541

10.2967/jnumed.115.157909

10.1148/radiol.2333031484

10.1148/rg.291085100

Avril, 2001, Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis, J Nucl Med., 42, 9

Avril, 2000, Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations, J Clin Oncol., 18, 3495, 10.1200/JCO.2000.18.20.3495

10.1200/JCO.20.2.379

10.1007/s00259-002-0880-8

10.1007/s00259-015-3080-z

10.2967/jnumed.115.161455

10.1002/jlcr.1956

10.1200/JCO.2007.10.6823

10.2967/jnumed.115.157875

10.1200/JCO.2013.54.8800

Jones, 2015, The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis, Ann Surg Oncol., 22, 3574, 10.1245/s10434-015-4391-9

Kwee, 2015, PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer, PET Clin., 10, 197, 10.1016/j.cpet.2014.12.003

10.1038/sj.bjc.6602787

10.1007/s10549-012-2233-z

Mamtani, 2016, How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study, Ann Surg Oncol., 23, 3467, 10.1245/s10434-016-5246-8

Edge S Byrd D Compton C . AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.